This week marked the end of my first year as CEO of APhA. From the moment I stepped into APhA headquarters, the World Home of Pharmacy, I was humbled by this amazing organization and all that APhA has accomplished in its 169-year history. I take very seriously the responsibility that comes with leading this storied institution. I've never doubted that the members of this profession had the mettle to look a dragon in the eye and slay it, but this year I've watched that talent and fortitude in action, and it's perhaps the most unforgettable sight of my life. The honor of supporting and advocating for our pharmacy heroes has changed my life forever and together, we’re changing the world for good. 

WASHINGTON, DC—The American Pharmacists Association (APhA) today joined the National Community Pharmacists Association (NCPA) as an equal partner in a federal lawsuit challenging a confusing scheme of retroactive fees imposed on pharmacies and, indirectly, their patients.

Researchers from the University of Michigan examined vaccination against human papillomavirus (HPV) in young adults versus adolescents for an 8-year period, from 2010 to 2018. Regardless of what age they were at first dose, more survey respondents opted for vaccination as the years passed. Still, compared with adolescents—68% of whom received one or more HPV doses by 2018—overall takeup among young adults was low.

The Institute for Safe Medication Practices (ISMP) continues to track the errors that have been reported from the currently authorized COVID-19 vaccines.